openPR Logo
Press release

Global Injectable Drug Delivery Market Opportunity Assessment, Market Challenges, Key vendor analysis, Vendor landscape by 2024

09-20-2017 12:14 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Injectable Drug Delivery Market 2017 – Industry Trends and Forecast to 2024

Global Injectable Drug Delivery Market 2017 – Industry Trends and Forecast to 2024

Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma& Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024.

Global Injectable Drug Delivery Marketis expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. On the other hand, safety concerns regarding the use of injectables, increased risk of blood-borne infections due to injectables, and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.

Ask for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market

Global Injectable Drug Delivery Market Key Drivers:

• Needlestick injuries and infections, regulatory hurdles, and preference for alternate modes of drug delivery are the factors which may hinder the growth of this market.
• Many companies are increasingly focusing on biologics and self-injection devices in order to strengthen their product portfolios in the injectable drug delivery market.
• Development of self-injection devices is changing the trend for the administration of injections in the healthcare sector.
• Increasing demand for biosimilars and generic injectables will drive the market in future.

Questions? We’ll Put You On The Right Path Request AnAnylst call: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-injectable-drug-delivery-market

Global Injectable Drug Delivery Market Segmentation:

The Global Injectable Drug Delivery Market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography. The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.In 2017, the injectable drug delivery formulation segment is expected to dominate the market with a share of ~75.0% and is expected to continue this trend till 2024.

Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

Know More AboutGlobal Injectable Drug Delivery Market: http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024.
Read more about the Global Injectable Drug Delivery Market :http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/

Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/north-america-digital-health-monitoring-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Data Bridge is an organization lead by well versed forecasters, analysts and researchers who indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. Data Bridge aims to make your organization well acquainted with profound knowledge of the global and local market statistics.

Data Bridge Market Research
Office Number 402 & 317, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Injectable Drug Delivery Market Opportunity Assessment, Market Challenges, Key vendor analysis, Vendor landscape by 2024 here

News-ID: 729098 • Views: 102

More Releases from Data Bridge Market Research

Global HbA1c Testing Market Size, Share, Growth Analysis, Global Trends, Industr …
Global HbA1c testing market is set to witness a healthy CAGR of 10.25% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing diabetes and rising health awareness among population is the factor for the growth of this market. This HbA1c testing market analysis report endows with the plentiful insights and business solutions that will help to stay ahead of
Europe Ophthalmology Drugs and Devices Market size, Insights, Prospects, Growth …
Ophthalmology drugs & devices market is expected to grow in the forecast period from 2020 to 2027. Data Bridge Market Research analyses the market for USD 13.81 billion by 2027, growing at a CAGR of 5.45% over the above-mentioned forecast period. The growth of Europe ophthalmology drugs & devices market is attributed to growing incidences of eye diseases. The ophthalmology drugs & devices market report aids to concentrate on the important
Global Foot Orthotic Insoles Market Incredible Possibilities, Growth With Indust …
Global foot orthotic insoles market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 5.76 Billion by 2027 growing at a CAGR of 6.04% in the above mentioned forecast period. The growth of foot orthotic insoles market is growing due to rise in occurrence of people suffering from arthritis, increase in geriatric and obese
Global Next-Generation Biomanufacturing Market 2020-2027 Detailed Analysis of Cu …
Next-generation biomanufacturing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 9.8% in the above-mentioned forecast period. The growing awareness among the people regarding the benefits next-generation biomanufacturing which will further boost various lucrative opportunities will lead to the growth of the market. Next-generation biomanufacturing market research report takes into consideration several

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning